|
TIMM9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.525000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.676200E-01 |
| Normal-vs-Stage2 |
6.499400E-01 |
| Normal-vs-Stage3 |
1.557650E-01 |
| Normal-vs-Stage4 |
1.775560E-02 |
| Stage1-vs-Stage2 |
4.528000E-01 |
| Stage1-vs-Stage3 |
1.612210E-01 |
| Stage1-vs-Stage4 |
6.621800E-04 |
| Stage2-vs-Stage3 |
1.516430E-01 |
| Stage2-vs-Stage4 |
2.978200E-03 |
| Stage3-vs-Stage4 |
8.762000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.710600E-01 |
| Normal-vs-AfricanAmerican |
2.123400E-01 |
| Normal-vs-Asian |
4.722600E-01 |
| Caucasian-vs-AfricanAmerican |
3.579400E-01 |
| Caucasian-vs-Asian |
3.201800E-01 |
| AfricanAmerican-vs-Asian |
5.926800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.960400E-01 |
| Normal-vs-Female |
2.024600E-01 |
| Male-vs-Female |
2.456600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.421210E-01 |
| Normal-vs-Extreme_Weight |
3.192800E-01 |
| Normal-vs-Obese |
2.227200E-01 |
| Normal-vs-Extreme_Obese |
8.021200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.401200E-01 |
| Normal_Weight-vs-Obese |
8.308600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.909400E-01 |
| Extreme_Weight-vs-Obese |
6.361800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.481600E-01 |
| Obese-vs-Extreme_Obese |
7.213800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.301400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.713800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.092400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.989000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.818400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.364400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.274200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.428400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.225000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.554000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.080200E-01 |
| Normal-VS-Type2 PRCC |
1.320960E-01 |
| Normal-VS-KIRP CIMP |
6.834600E-01 |
| Normal-VS-Unclassified PRCC |
1.539370E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.401620E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.203400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.133600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.488600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.098300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.057800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.858800E-01 |
| Normal-vs-N1 |
8.379300E-03 |
| Normal-vs-N2 |
3.869800E-01 |
| N0-vs-N1 |
1.907580E-02 |
| N0-vs-N2 |
4.958000E-01 |
| N1-vs-N2 |
1.348160E-01 |
|
|
